We report the case of a 48-year-old patient, undergoing an investigation of progressive dyspnea MRC grade II, during which an endoluminal polypoid lesion was revealed on X-ray. Fiberoptic bronchoscopy showed a hypervascularized pedunculated mass in the distal third of the trachea, next to the left main bronchus, obstructing 60%–70% of the lumen.
Given the characteristics of the tumor, we proceeded to resect it under rigid fiberoptic bronchoscopy control. Ligasure® was used for tumor resection. (Fig. 1). This is an advanced bipolar device that performs hemostasis by thermocoagulation, allowing us to resect and seal the pedicle under visual control, without diminishing FiO2.
The patient was discharged 48h after the procedure, without complications. When the diagnosis of hamartoma measuring 18mm was confirmed, we decided to follow up the patient with fiberoptic bronchoscopy and radiological control. The patient was asymptomatic and disease-free after 6 months of treatment.
Tracheal hamartoma is a rare benign tumor. Thanks to advances in interventional pulmonology, the successful endoscopic treatment of benign endotracheal lesions is now possible,1 although some authors defend surgical treatment.2 Given the benign nature of the lesion and the bronchoscopic outcomes described in the literature, we opted for endoscopic resection and follow-up.
Please cite this article as: Triviño A, Arroyo Pareja L, España C. Extirpación de hamartoma endobronquial con Ligasure®. Arch Bronconeumol. 2019;55:434.
